Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

RESMED INC Director's Dealing 2019

Nov 14, 2019

30071_dirs_2019-11-13_27112553-fdbf-4f8d-82b2-228a1281d354.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2019-11-11

Reporting Person: PENDARVIS DAVID (Chief Administrative Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2019-11-11 ResMed Common Stock M 1731 $57.76 Acquired 119440 Direct
2019-11-11 ResMed Common Stock F 860 $143.88 Disposed 118580 Direct
2019-11-11 ResMed Common Stock F 727 $143.88 Disposed 117853 Direct
2019-11-11 ResMed Common Stock F 1199 $143.88 Disposed 116654 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2019-11-11 ResMed Common Stock Options $57.76 M 1731 Disposed 2023-11-16 ResMed Commmon Stock (1731) Direct

Footnotes

F1: Includes 117.569 shares of ResMed stock purchased on October 31, 2019, through the ResMed Employee Stock Purchase Plan.

F2: Disposition to issuer for tax withholding on vesting of performance-based Restricted Stock Units granted on 11/16/2017.

F3: Disposition to issuer for tax withholding on vesting of performance-based Restricted Stock Units granted on 11/14/2018.

F4: Disposition to issuer for tax withholding on vesting of performance-based Restricted Stock Units granted on 11/16/2016.

F5: Represents date options first became exercisable. Options vest 1/3 per year.